Peptides like BPC-157 and TB-500 are not FDA-approved medications, and safety depends heavily on proper medical screening, dosing, and sourcing
This gives it a half-life long enough to support once-weekly dosing, a major practical advantage over earlier amylin-based therapies like pramlintide, which required multiple daily injections
Novo Nordisk filed the New Drug Application (NDA) for CagriSema in early 2026, based on positive results from the REDEFINE phase 3 trial program
BPC-157 and TB-500 should be clear
For most people, B12 shots are totally safe and well-tolerated
When evaluating the possible impact of CJC-1295 on bone length and body composition, the femur and tibia length appeared to remain within normal ranges, as well as lean mass and subcutaneous fat mass